These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 14765342

  • 1. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.
    Cherry JD, Xing DX, Newland P, Patel K, Heininger U, Corbel MJ.
    Clin Infect Dis; 2004 Feb 15; 38(4):502-7. PubMed ID: 14765342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
    Heininger U, Stehr K, Christenson P, Cherry JD.
    Clin Infect Dis; 1999 Mar 15; 28(3):602-4. PubMed ID: 10194085
    [Abstract] [Full Text] [Related]

  • 4. Serological responses to infection with B. pertussis.
    Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A.
    Dev Biol Stand; 1997 Mar 15; 89():213-20. PubMed ID: 9272353
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar 15; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 7. Serologic response and antibody-titer decay in adults with pertussis.
    Heininger U, Cherry JD, Stehr K.
    Clin Infect Dis; 2004 Feb 15; 38(4):591-4. PubMed ID: 14765356
    [Abstract] [Full Text] [Related]

  • 8. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
    Ausiello CM, Lande R, Urbani F, Di Carlo B, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A.
    J Infect Dis; 2000 Jun 15; 181(6):1989-95. PubMed ID: 10837180
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A field survey carried out on the confirmation of a pertussis case in a village of Kirikkale Province, Turkey].
    Coplü N, Nar S, Efsun A, Kurtoğlu D, Esen B.
    Mikrobiyol Bul; 2007 Apr 15; 41(2):175-83. PubMed ID: 17682703
    [Abstract] [Full Text] [Related]

  • 12. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
    Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, Bernstein DI, Edelman R, APERT Study Group.
    Clin Infect Dis; 2006 Jul 15; 43(2):151-7. PubMed ID: 16779740
    [Abstract] [Full Text] [Related]

  • 13. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases.
    Pediatrics; 2006 Mar 15; 117(3):965-78. PubMed ID: 16382131
    [Abstract] [Full Text] [Related]

  • 14. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
    Syed MA, Ahmed W, Naeem A, Bokhari H.
    J Coll Physicians Surg Pak; 2012 Oct 15; 22(10):677-8. PubMed ID: 23058160
    [Abstract] [Full Text] [Related]

  • 15. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T, Cherry JD, Heininger U.
    Vaccine; 2005 Oct 17; 23(43):5106-12. PubMed ID: 16023771
    [Abstract] [Full Text] [Related]

  • 16. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM, Predy G, Guasparini R, Law B, Diaz-Mitoma F, Whitstitt P, Tapiero B, Dionne M, Tomovici A, Mills E, Halperin SA.
    Vaccine; 2007 Jan 22; 25(6):1121-5. PubMed ID: 17045366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J, Trollfors B, Bergfors E, Knutsson N, Sundh V, Lagergård T, Lind-Brandberg L, Zackrisson G, White J, Cicirello H, Fusco J, Robbins JB.
    Clin Infect Dis; 2001 Oct 01; 33(7):1004-10. PubMed ID: 11528572
    [Abstract] [Full Text] [Related]

  • 19. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
    Abzug MJ, Song LY, Fenton T, Nachman SA, Levin MJ, Rosenblatt HM, Pelton SI, Borkowsky W, Edwards KM, Peters J, International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 Protocol Team.
    Pediatrics; 2007 Nov 01; 120(5):e1190-202. PubMed ID: 17938165
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.